Corbus Pharmaceuticals Holdings (CRBP) Assets Average (2014 - 2025)

Corbus Pharmaceuticals Holdings has reported Assets Average for 12 years, with the latest figure at $138.9 million in Q4 2025.

• On a quarterly basis, Assets Average fell 13.23% year-over-year to $138.9 million in Q4 2025; TTM through Dec 2025 was $138.9 million, a 13.23% decrease from a year earlier, with the FY2025 full-year figure at $162.0 million, up 75.98% from the prior year.
• Assets Average was $138.9 million for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $117.3 million in the prior quarter.
• The five-year high for Assets Average was $160.0 million in Q4 2024, with the low at $32.3 million in Q4 2023.
• Average Assets Average over 5 years is $103.7 million, with a median of $115.5 million recorded in 2021.
• The sharpest annual moves came in 2023 and 2024: Assets Average tumbled 53.94% in 2023, then surged 395.78% in 2024.
• Over 5 years, Assets Average stood at $113.7 million in 2021, then slumped by 38.35% to $70.1 million in 2022, then plunged by 53.94% to $32.3 million in 2023, then soared by 395.78% to $160.0 million in 2024, then retreated by 13.23% to $138.9 million in 2025.
• The last three Assets Average figures came in at $138.9 million (Q4 2025), $117.3 million (Q3 2025), and $132.5 million (Q2 2025), per Business Quant data.